METTL10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.966000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.995800E-01
Normal-vs-Stage2
6.648600E-01
Normal-vs-Stage3
8.381800E-01
Normal-vs-Stage4
9.932200E-01
Stage1-vs-Stage2
7.725800E-01
Stage1-vs-Stage3
5.627200E-01
Stage1-vs-Stage4
4.114200E-01
Stage2-vs-Stage3
7.631200E-01
Stage2-vs-Stage4
6.131200E-01
Stage3-vs-Stage4
8.441000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.867200E-01
Normal-vs-AfricanAmerican
5.630400E-01
Normal-vs-Asian
9.975600E-01
Caucasian-vs-AfricanAmerican
7.828800E-01
Caucasian-vs-Asian
3.078400E-01
AfricanAmerican-vs-Asian
5.551000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.127400E-01
Normal-vs-Female
5.836200E-01
Male-vs-Female
4.472000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.345200E-01
Normal-vs-Age(41-60Yrs)
3.305600E-01
Normal-vs-Age(61-80Yrs)
6.846400E-01
Normal-vs-Age(81-100Yrs)
6.120400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.955000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.108000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.751400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.166600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.050000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.116200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.895600E-01
Normal-vs-Daily Drinker
6.698200E-01
Normal-vs-Weekly Drinker
2.855600E-01
Normal-vs-Occasional Drinker
2.576600E-01
Normal-vs-Social Drinker
4.728600E-01
Non Drinker-vs-Daily Drinker
8.637200E-01
Non Drinker-vs-Weekly Drinker
4.352600E-01
Non Drinker-vs-Occasional Drinker
1.471370E-01
Non Drinker-vs-Social Drinker
5.745800E-01
Daily Drinker-vs-Weekly Drinker
4.822600E-01
Daily Drinker-vs-Occasional Drinker
2.602400E-01
Daily Drinker-vs-Social Drinker
7.272200E-01
Weekly Drinker-vs-Occasional Drinker
8.267200E-01
Weekly Drinker-vs-Social Drinker
5.843800E-01
Occasional Drinker-vs-Social Drinker
4.412400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.564360E-01
Normal-vs-Grade 2
8.478300E-02
Normal-vs-Grade 3
3.718100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.543750E-01
Grade 1-vs-Grade 3
7.632000E-02
Grade 1-vs-Grade 4
1.564360E-01
Grade 2-vs-Grade 3
6.940600E-01
Grade 2-vs-Grade 4
8.478300E-02
Grade 3-vs-Grade 4
3.718100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.892400E-01
Normal-vs-NonDiabetic
6.065200E-01
Diabetic-vs-NonDiabetic
2.844200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.838200E-01
Normal-vs-NoPancreatitis
6.104000E-01
Pancreatitis-vs-NoPancreatitis
9.841600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.202400E-01
Normal-vs-N1
7.005000E-01
N0-vs-N1
1.448170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.810300E-02
Normal-vs-TP53-NonMutant
4.859000E-01
TP53-Mutant-vs-TP53-NonMutant
3.254200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
